Head-to-head · Cost-Efficiency Index
ShapeIn Rx vs Evernow
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
ShapeIn Rx
Cost-first shoppers who want budget-focused semaglutide-only shoppers, not tirzepatide seekers.
Visit ShapeIn RxEvernow
Cost-first shoppers who want women 40+ wanting GLP-1 prescribing integrated with menopause/hormone care, ideally with insurance.
Visit EvernowThe verdict
ShapeIn Rx takes it, leading the Cost-Efficiency Index 50 to 49. ShapeIn Rx (shapeinrx.com) currently sells only compounded semaglutide and liraglutide -- tirzepatide and all branded GLP-1s are listed as 'Coming soon' and are not actually purchasable today. Evernow still earns a C — Cost-first shoppers who want women 40+ wanting GLP-1 prescribing integrated with menopause/hormone care, ideally with insurance.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs ShapeIn Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | ShapeIn Rx | Evernow |
|---|---|---|
| Cost-Efficiency Index | 50/100 | 49/100 |
| Semaglutide / mo | $249/mo (compounded) | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | $2,988 | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #414 | #421 |
ShapeIn Rx
50/100Where the value is
- Detailed tiered pricing published directly on a dedicated /pricing page
- LegitScript badge displayed
- Multiple dose tiers (up to 1mg, up to 2.5mg) let patients see a cost ladder
The tradeoffs
- Tirzepatide is not actually available -- all tirzepatide tiers are marked 'Coming soon'
- Homepage's $149/month promo banner doesn't match any real tier on the actual pricing page
Evernow
49/100Where the value is
- Confirmed genuine GLP-1 prescribing (not hormone-therapy-only, despite the brand's menopause focus)
- Only prescribes FDA-approved branded medications, no compounded-drug quality uncertainty
- Available in all 50 states plus D.C.
The tradeoffs
- No cash-pay price published anywhere -- cost is insurance-dependent and opaque to uninsured shoppers
- No compounded option for patients priced out of branded GLP-1s
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.